 Nikoloz Shkriabai
Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 12 | 2025 | 834 | 1.080 |
Why?
| | HIV Integrase | 9 | 2017 | 70 | 1.050 |
Why?
| | HIV Integrase Inhibitors | 5 | 2016 | 69 | 0.730 |
Why?
| | Human T-lymphotropic virus 1 | 5 | 2023 | 28 | 0.700 |
Why?
| | Virus Integration | 9 | 2022 | 69 | 0.550 |
Why?
| | Acetates | 2 | 2014 | 99 | 0.550 |
Why?
| | Anti-HIV Agents | 4 | 2025 | 751 | 0.440 |
Why?
| | Indoles | 1 | 2014 | 372 | 0.370 |
Why?
| | Protein Binding | 17 | 2021 | 2110 | 0.360 |
Why?
| | DNA, Viral | 5 | 2017 | 348 | 0.330 |
Why?
| | Drug Resistance, Viral | 3 | 2014 | 110 | 0.310 |
Why?
| | Virus Replication | 4 | 2025 | 444 | 0.300 |
Why?
| | Mutation, Missense | 3 | 2014 | 315 | 0.290 |
Why?
| | Gene Products, tax | 2 | 2019 | 13 | 0.280 |
Why?
| | HEK293 Cells | 11 | 2020 | 683 | 0.280 |
Why?
| | Cell Cycle Proteins | 5 | 2017 | 581 | 0.270 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2013 | 372 | 0.260 |
Why?
| | Viral Nonstructural Proteins | 2 | 2016 | 58 | 0.260 |
Why?
| | RNA, Viral | 4 | 2017 | 615 | 0.250 |
Why?
| | DNA Damage | 3 | 2021 | 370 | 0.240 |
Why?
| | Integrases | 3 | 2017 | 118 | 0.240 |
Why?
| | Hepacivirus | 2 | 2016 | 235 | 0.230 |
Why?
| | Acetamides | 1 | 2025 | 36 | 0.230 |
Why?
| | Indazoles | 1 | 2025 | 65 | 0.230 |
Why?
| | Virus Assembly | 1 | 2025 | 76 | 0.220 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 65 | 0.220 |
Why?
| | Leukemia Virus, Murine | 2 | 2014 | 17 | 0.220 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 5 | 0.220 |
Why?
| | Capsid | 2 | 2021 | 90 | 0.210 |
Why?
| | Protein Multimerization | 2 | 2014 | 178 | 0.200 |
Why?
| | Transcription Factors | 3 | 2017 | 1635 | 0.200 |
Why?
| | Prions | 1 | 2022 | 46 | 0.200 |
Why?
| | Nucleosomes | 2 | 2014 | 137 | 0.190 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 39 | 0.180 |
Why?
| | Necrosis | 1 | 2021 | 229 | 0.170 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 84 | 0.170 |
Why?
| | Protein Interaction Domains and Motifs | 4 | 2019 | 138 | 0.170 |
Why?
| | Neuroblastoma | 1 | 2021 | 153 | 0.170 |
Why?
| | HTLV-I Infections | 3 | 2019 | 22 | 0.160 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.150 |
Why?
| | Receptors, Virus | 1 | 2019 | 83 | 0.150 |
Why?
| | Nuclear Proteins | 2 | 2014 | 658 | 0.150 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 349 | 0.150 |
Why?
| | Avian Leukosis Virus | 1 | 2017 | 6 | 0.140 |
Why?
| | Allosteric Regulation | 2 | 2014 | 98 | 0.140 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 42 | 0.140 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 36 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1423 | 0.130 |
Why?
| | Cyclophilin A | 1 | 2016 | 26 | 0.130 |
Why?
| | Mass Spectrometry | 7 | 2016 | 663 | 0.130 |
Why?
| | Ribonuclease P | 1 | 2016 | 25 | 0.130 |
Why?
| | Nucleic Acids | 1 | 2016 | 60 | 0.130 |
Why?
| | Virion | 1 | 2016 | 82 | 0.130 |
Why?
| | Genome, Viral | 1 | 2016 | 129 | 0.120 |
Why?
| | Models, Molecular | 7 | 2017 | 1484 | 0.120 |
Why?
| | RNA, Transfer | 1 | 2016 | 130 | 0.120 |
Why?
| | Catalytic Domain | 1 | 2016 | 217 | 0.120 |
Why?
| | Calcium | 1 | 2021 | 1183 | 0.120 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 40 | 0.120 |
Why?
| | Hepatitis C | 1 | 2016 | 237 | 0.110 |
Why?
| | Quinolines | 1 | 2014 | 155 | 0.110 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 43 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 420 | 0.100 |
Why?
| | Capsid Proteins | 2 | 2025 | 90 | 0.100 |
Why?
| | beta Karyopherins | 1 | 2012 | 6 | 0.100 |
Why?
| | Cell Nucleus | 2 | 2021 | 580 | 0.100 |
Why?
| | Protein Domains | 3 | 2020 | 252 | 0.100 |
Why?
| | Viral Proteins | 1 | 2014 | 323 | 0.100 |
Why?
| | Crystallography, X-Ray | 3 | 2020 | 434 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 453 | 0.100 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 27 | 0.090 |
Why?
| | Amino Acid Motifs | 3 | 2021 | 211 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 137 | 0.090 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2022 | 36 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 2019 | 2044 | 0.090 |
Why?
| | HIV Infections | 2 | 2025 | 2711 | 0.090 |
Why?
| | HIV Reverse Transcriptase | 1 | 2011 | 30 | 0.090 |
Why?
| | Humans | 24 | 2025 | 128495 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 13 | 0.090 |
Why?
| | Viral Core Proteins | 1 | 2011 | 21 | 0.090 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2011 | 82 | 0.090 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 55 | 0.090 |
Why?
| | Aptamers, Nucleotide | 1 | 2011 | 77 | 0.090 |
Why?
| | Virology | 1 | 2010 | 23 | 0.090 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 65 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 145 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1291 | 0.080 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 108 | 0.080 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 1 | 2009 | 5 | 0.080 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 837 | 0.080 |
Why?
| | Binding Sites | 3 | 2021 | 1244 | 0.080 |
Why?
| | DNA Footprinting | 1 | 2008 | 33 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 398 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 313 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 416 | 0.070 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 178 | 0.070 |
Why?
| | DNA Repair | 1 | 2009 | 206 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 420 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 380 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 112 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 606 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1045 | 0.060 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 15 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 81 | 0.050 |
Why?
| | Cell Line | 3 | 2014 | 2741 | 0.050 |
Why?
| | Drugs, Investigational | 1 | 2022 | 32 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 65 | 0.050 |
Why?
| | Phosphorylation | 2 | 2021 | 1686 | 0.050 |
Why?
| | Glycine | 1 | 2022 | 163 | 0.050 |
Why?
| | Nuclear Pore | 1 | 2021 | 16 | 0.050 |
Why?
| | Reverse Transcription | 1 | 2021 | 18 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 573 | 0.050 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 13 | 0.050 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 29 | 0.040 |
Why?
| | Cytoplasm | 1 | 2021 | 258 | 0.040 |
Why?
| | Protein Conformation | 2 | 2014 | 854 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 539 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 4 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 11 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 10 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 930 | 0.040 |
Why?
| | Chromatography, Gel | 2 | 2009 | 127 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1199 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 583 | 0.040 |
Why?
| | Histones | 2 | 2014 | 588 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2822 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 311 | 0.040 |
Why?
| | Virulence | 1 | 2019 | 255 | 0.040 |
Why?
| | Nucleoproteins | 1 | 2017 | 28 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 130 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1076 | 0.030 |
Why?
| | Nucleocapsid | 1 | 2016 | 18 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1394 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2017 | 227 | 0.030 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2016 | 84 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 142 | 0.030 |
Why?
| | Morphogenesis | 1 | 2016 | 156 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 366 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 149 | 0.030 |
Why?
| | Retroviridae Proteins | 1 | 2014 | 11 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 4825 | 0.030 |
Why?
| | Histidine | 1 | 2014 | 58 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1191 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2014 | 99 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 797 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 141 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 131 | 0.030 |
Why?
| | Azepines | 1 | 2013 | 88 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 456 | 0.030 |
Why?
| | Base Sequence | 1 | 2016 | 2137 | 0.030 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 20 | 0.030 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 94 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 148 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 186 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2437 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 281 | 0.020 |
Why?
| | Triazoles | 1 | 2013 | 151 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1698 | 0.020 |
Why?
| | Protein Footprinting | 1 | 2011 | 11 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1830 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 650 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 441 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 36 | 0.020 |
Why?
| | Animals | 4 | 2017 | 34647 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 130 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 92 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 52 | 0.020 |
Why?
| | Retroviridae | 1 | 2010 | 99 | 0.020 |
Why?
| | Protein Subunits | 1 | 2011 | 230 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2010 | 213 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2013 | 487 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 148 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 777 | 0.020 |
Why?
| | Point Mutation | 1 | 2009 | 225 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 122 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 340 | 0.020 |
Why?
| | Proteomics | 1 | 2013 | 1018 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3178 | 0.020 |
Why?
| | Proteins | 1 | 2010 | 936 | 0.010 |
Why?
| | Peptides | 1 | 2009 | 915 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3696 | 0.010 |
Why?
| | Mice | 1 | 2013 | 16620 | 0.010 |
Why?
|
|
Shkriabai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|